SEASPINE HOLDINGS CORP (SPNE) Fundamental Analysis & Valuation

NASDAQ:SPNE • US81255T1088

Current stock price

9.54 USD
+0.73 (+8.29%)
At close:
9.35 USD
-0.19 (-1.99%)
After Hours:

This SPNE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. SPNE Profitability Analysis

1.1 Basic Checks

  • SPNE had negative earnings in the past year.
  • In the past year SPNE has reported a negative cash flow from operations.
SPNE Yearly Net Income VS EBIT VS OCF VS FCFSPNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 -20M -40M -60M

1.2 Ratios

  • The profitability ratios for SPNE are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SPNE Yearly ROA, ROE, ROICSPNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 -10 -20 -30

1.3 Margins

  • SPNE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SPNE Yearly Profit, Operating, Gross MarginsSPNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 20 -20 40 60

3

2. SPNE Health Analysis

2.1 Basic Checks

  • SPNE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, SPNE has more shares outstanding
  • There is no outstanding debt for SPNE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SPNE Yearly Shares OutstandingSPNE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 10M 20M 30M
SPNE Yearly Total Debt VS Total AssetsSPNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 100M 200M 300M

2.2 Solvency

  • SPNE has an Altman-Z score of 1.40. This is a bad value and indicates that SPNE is not financially healthy and even has some risk of bankruptcy.
  • SPNE has a Altman-Z score of 1.40. This is comparable to the rest of the industry: SPNE outperforms 49.08% of its industry peers.
  • A Debt/Equity ratio of 0.09 indicates that SPNE is not too dependend on debt financing.
  • With a Debt to Equity ratio value of 0.09, SPNE perfoms like the industry average, outperforming 53.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Altman-Z 1.4
ROIC/WACCN/A
WACC8.68%
SPNE Yearly LT Debt VS Equity VS FCFSPNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 100M 200M 300M

2.3 Liquidity

  • SPNE has a Current Ratio of 3.18. This indicates that SPNE is financially healthy and has no problem in meeting its short term obligations.
  • SPNE has a Current ratio (3.18) which is in line with its industry peers.
  • A Quick Ratio of 1.65 indicates that SPNE should not have too much problems paying its short term obligations.
  • SPNE has a worse Quick ratio (1.65) than 67.89% of its industry peers.
Industry RankSector Rank
Current Ratio 3.18
Quick Ratio 1.65
SPNE Yearly Current Assets VS Current LiabilitesSPNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 50M 100M 150M

5

3. SPNE Growth Analysis

3.1 Past

  • The earnings per share for SPNE have decreased strongly by -20.41% in the last year.
  • The Revenue has grown by 26.03% in the past year. This is a very strong growth!
  • SPNE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.23% yearly.
EPS 1Y (TTM)-20.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.5%
Revenue 1Y (TTM)26.03%
Revenue growth 3Y10.11%
Revenue growth 5Y8.23%
Sales Q2Q%44.57%

3.2 Future

  • Based on estimates for the next years, SPNE will show a small growth in Earnings Per Share. The EPS will grow by 2.06% on average per year.
  • SPNE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.60% yearly.
EPS Next Y-1.82%
EPS Next 2Y8.56%
EPS Next 3Y11.83%
EPS Next 5Y2.06%
Revenue Next Year24.57%
Revenue Next 2Y17.4%
Revenue Next 3Y16.89%
Revenue Next 5Y11.6%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SPNE Yearly Revenue VS EstimatesSPNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
SPNE Yearly EPS VS EstimatesSPNE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -1 -2 -3

0

4. SPNE Valuation Analysis

4.1 Price/Earnings Ratio

  • SPNE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year SPNE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SPNE Price Earnings VS Forward Price EarningsSPNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SPNE Per share dataSPNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.56%
EPS Next 3Y11.83%

0

5. SPNE Dividend Analysis

5.1 Amount

  • No dividends for SPNE!.
Industry RankSector Rank
Dividend Yield N/A

SPNE Fundamentals: All Metrics, Ratios and Statistics

SEASPINE HOLDINGS CORP

NASDAQ:SPNE (1/4/2023, 8:00:02 PM)

After market: 9.35 -0.19 (-1.99%)

9.54

+0.73 (+8.29%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-01
Earnings (Next)03-09
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners6.42%
Ins Owner Change0%
Market Cap354.91M
Revenue(TTM)229.75M
Net Income(TTM)-64.84M
Analysts85.71
Price Target16.13 (69.08%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-20.48%
Min EPS beat(2)-35%
Max EPS beat(2)-5.95%
EPS beat(4)0
Avg EPS beat(4)-27.95%
Min EPS beat(4)-47.45%
Max EPS beat(4)-5.95%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)0.92%
Min Revenue beat(2)0.23%
Max Revenue beat(2)1.61%
Revenue beat(4)3
Avg Revenue beat(4)0.68%
Min Revenue beat(4)-0.65%
Max Revenue beat(4)1.61%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.54
P/FCF N/A
P/OCF N/A
P/B 1.29
P/tB 2.31
EV/EBITDA N/A
EPS(TTM)-1.77
EYN/A
EPS(NY)-1.33
Fwd EYN/A
FCF(TTM)-2.16
FCFYN/A
OCF(TTM)-1.22
OCFYN/A
SpS6.18
BVpS7.38
TBVpS4.12
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 212.78%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.18
Quick Ratio 1.65
Altman-Z 1.4
F-Score3
WACC8.68%
ROIC/WACCN/A
Cap/Depr(3y)159.81%
Cap/Depr(5y)125.57%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-20.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.5%
EPS Next Y-1.82%
EPS Next 2Y8.56%
EPS Next 3Y11.83%
EPS Next 5Y2.06%
Revenue 1Y (TTM)26.03%
Revenue growth 3Y10.11%
Revenue growth 5Y8.23%
Sales Q2Q%44.57%
Revenue Next Year24.57%
Revenue Next 2Y17.4%
Revenue Next 3Y16.89%
Revenue Next 5Y11.6%
EBIT growth 1Y-27.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year71.08%
EBIT Next 3Y25.82%
EBIT Next 5Y14.6%
FCF growth 1Y-150.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-136.29%
OCF growth 3YN/A
OCF growth 5YN/A

SEASPINE HOLDINGS CORP / SPNE Fundamental Analysis FAQ

What is the fundamental rating for SPNE stock?

ChartMill assigns a fundamental rating of 3 / 10 to SPNE.


What is the valuation status of SEASPINE HOLDINGS CORP (SPNE) stock?

ChartMill assigns a valuation rating of 2 / 10 to SEASPINE HOLDINGS CORP (SPNE). This can be considered as Overvalued.


How profitable is SEASPINE HOLDINGS CORP (SPNE) stock?

SEASPINE HOLDINGS CORP (SPNE) has a profitability rating of 1 / 10.


How financially healthy is SEASPINE HOLDINGS CORP?

The financial health rating of SEASPINE HOLDINGS CORP (SPNE) is 4 / 10.


What is the expected EPS growth for SEASPINE HOLDINGS CORP (SPNE) stock?

The Earnings per Share (EPS) of SEASPINE HOLDINGS CORP (SPNE) is expected to decline by -1.82% in the next year.